Esperion to Participate in Jefferies London Healthcare Conference
31 October 2023 - 11:00PM
Esperion (NASDAQ: ESPR) today announced its participation in the
Jefferies London Healthcare Conference. Sheldon Koenig, President
and Chief Executive Officer, will participate in a fireside chat on
Tuesday, November 14, 2023 at 3:00 AM ET. The Esperion management
team will also host investor meetings that same day.
To register for the live webcast, follow this link.
A live audio webcast can be accessed on the investor and media
section of the Esperion website. Access to the webcast replay will
be available approximately two hours after completion of the call
and will be archived on the Company's website for approximately 90
days.
Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative
medicines to help improve outcomes for patients with or at risk for
cardiovascular and cardiometabolic diseases. The status quo is not
meeting the health needs of millions of people with high
cholesterol – that is why our team of passionate industry leaders
is breaking through the barriers that prevent patients from
reaching their goals. Providers are moving toward reducing
LDL-cholesterol levels as low as possible, as soon as possible; we
provide the next steps to help get patients there. Because when it
comes to high cholesterol, getting to goal is not optional. It is
our life’s work. For more information, visit esperion.com and
esperionscience.com and follow us on Twitter at
twitter.com/EsperionInc.
Esperion Contact Information: Investors:
Alexis Callahaninvestorrelations@esperion.com(406)
539-1762 Media: Tiffany Aldrich
corporateteam@esperion.com(616) 443-8438
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Apr 2024 to May 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From May 2023 to May 2024